Previous Article | Next Article ![]()
Journal of Virology, June 2006, p. 5631-5636, Vol. 80, No. 11
0022-538X/06/$08.00+0 doi:10.1128/JVI.00219-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115,1 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 021152
Received 31 January 2006/ Accepted 7 March 2006
Human TRIM5
(TRIM5
hu) potently restricts N-tropic (N-MLV), but not B-tropic, murine leukemia virus in a manner dependent upon residue 110 of the viral capsid. Rhesus monkey TRIM5
(TRIM5
rh) inhibits N-MLV only weakly. The study of human-monkey TRIM5
chimerae revealed that both the v1 and v3 variable regions of the B30.2/SPRY domain contain potency determinants for N-MLV restriction. These variable regions are predicted to be surface-exposed elements on one face of the B30.2 domain. Acidic residues in v3 complement basic residue 110 of the N-MLV capsid. The results support recognition of the retroviral capsid by the TRIM5
B30.2 domain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|